Lipopolysaccharide‐induced monocyte chemotactic protein‐1 is enhanced by suppression of nitric oxide production, which depends on poor CD14 expression on the surface of skeletal muscle
Authors:
- 31 March 2008
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 26 (4) , 486-492
Abstract
It is known that lipopolysaccharide (LPS)‐induced monocyte chemotactic protein (MCP)‐1 secretion from tissues recruits monocytes from the circulation, but the mechanism of the LPS‐induced MCP‐1 production in skeletal muscle is largely unexplained. To clarify the effect of LPS on MCP‐1 production in skeletal muscle cells, C2C12 cells from a mouse skeletal muscle cell line, and RAW 264.7 cells from a mouse macrophage cell line, were used to assess production of LPS‐induced MCP‐1, nitric oxide (NO) and interferon (IFN)‐β. In addition, we evaluated inducible NO synthases (iNOS) mRNA expression using RT‐PCR, and cell surface expression of CD14 and toll‐like receptor (TLR) 4 using flow cytometry. In C2C12 cells, LPS stimulation increased MCP‐1 production (p < 0.01), but combined treatment with LPS and NO inducer, diethylammonium (Z)‐1‐(N,N‐diethylamino) diazen‐1‐ium‐1,2‐diolate (NONOate), significantly inhibited its production (p < 0.01). LPS stimulation neither induced production of NO nor of IFN‐β, which is an NO inducer. Recombinant IFN‐β stimulation, on the other hand, enhanced LPS‐induced NO production (p < 0.01). Interestingly, we found that surface expression of CD14, which regulates IFN‐β production, in C2C12 cells was much lower than that in RAW 264.7 cells, although TLR4 expression on C2C12 cells was similar to that on RAW 264.7 cells. These data suggest that the reduced NO production in response to LPS may depend on low expression of CD14 on the cell surface of skeletal muscle, and that it may enhance LPS‐induced MCP‐1 production. Together, these functions of skeletal muscle could decrease the risk of bacterial infection by recruitment of monocytes. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Toll-Like Receptors Differentially Regulate CC and CXC Chemokines in Skeletal Muscle via NF-κB and CalcineurinInfection and Immunity, 2006
- MCP-1 deficiency causes altered inflammation with impaired skeletal muscle regenerationJournal of Leukocyte Biology, 2006
- CD14 is required for MyD88-independent LPS signalingNature Immunology, 2005
- Lipopolysaccharide stimulates nitric oxide synthase-2 expression in murine skeletal muscle and C2C12 myoblasts via Toll-like receptor-4 and c-Jun NH2-terminal kinase pathwaysAmerican Journal of Physiology-Cell Physiology, 2004
- Regulation of the expression of inducible nitric oxide synthaseEuropean Journal of Pharmacology, 2004
- Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4Immunology, 2004
- Null Mutation of gp91phox Reduces Muscle Membrane Lysis During Muscle Inflammation in MiceThe Journal of Physiology, 2003
- Augmentation of Nitric Oxide Production by Gamma Interferon in a Mouse Vascular Endothelial Cell Line and Its Modulation by Tumor Necrosis Factor Alpha and LipopolysaccharideInfection and Immunity, 2000
- Nitric Oxide-Mediated Modulation of Interleukin-8 Production by a Human Glioblastoma Cell Line, T98G, Cocultured with Myeloid and Monocytic Cell LinesJournal of Interferon & Cytokine Research, 1998
- Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.Journal of Clinical Investigation, 1995